Baxter International | BAX - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Abbott USD 5.3B 380M 2026-03
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 31.94M 3.22M 2026-03
Avanos Medical USD 88M 6.9M 2026-03
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Fresenius EUR 4.45B 262M 2025-12
Globus Medical USD 263.59M 26.88M 2026-03
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
ICU Medical USD 337.72M 1.61M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Quest Diagnostics USD 1.99B 57M 2026-03
Smith & Nephew USD 870M 17M 2025-12
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Terumo JPY 151.3B 7.86B 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03